Skip to main content
PLOS One logoLink to PLOS One
. 2024 Apr 16;19(4):e0294461. doi: 10.1371/journal.pone.0294461

Chest pain in pediatric patients in the emergency department- Presentation, risk factors and outcomes-A systematic review and meta-analysis

Mohammed Alsabri 1,*, Alaa Ahmed Elshanbary 2,*, Anas Zakarya Nourelden 3, Ahmed Hashem Fathallah 4, Mohamed Sayed Zaazouee 5,*, Jorge Pincay 6, Zaid Nakadar 6, Muhammad Wasem 7, Lita Aeder 8
Editor: Antoine Fakhry AbdelMassih9
PMCID: PMC11020527  PMID: 38626180

Abstract

Objective

This study aimed to assess and determine the presentation, risk factors, and outcomes of pediatric patients who were admitted for cardiac-related chest pain.

Background

Although chest pain is common in children, most cases are due to non-cardiac etiology. The risk of misdiagnosis and the pressure of potentially adverse outcomes can lead to unnecessary diagnostic testing and overall poorer patient experiences. Additionally, this can lead to a depletion of resources that could be better allocated towards patients who are truly suffering from cardiac-related pathology.

Methods

This review was conducted per PRISMA guidelines. This systematic review used several databases including MEDLINE, Embase, Scopus, and Web of Science to obtain its articles for review.

Results

A total of 6,520 articles were identified, and 11 articles were included in the study. 2.5% of our study population was found to have cardiac-related chest pain (prevalence = 0.025, 95% CI [0.013, 0.038]). The most commonly reported location of pain was retrosternal chest pain. 97.5% of the study population had a non-cardiac cause of chest pain, with musculoskeletal pain being identified as the most common cause (prevalence = 0.357, 95% CI [0.202, 0.512]), followed by idiopathic (prevalence = 0.352, 95% CI [0.258, 0.446]) and then gastrointestinal causes (prevalence = 0.053, 95% CI [0.039, 0.067]).

Conclusions

The overwhelming majority of pediatric chest pain cases stem from benign origins. This comprehensive analysis found musculoskeletal pain as the predominant culprit behind chest discomfort in children. Scrutinizing our study cohort revealed that retrosternal chest pain stands as the unequivocal epicenter of this affliction. Thorough evaluation of pediatric patients manifesting with chest pain is paramount for the delivery of unparalleled care, especially in the context of potential cardiac risks in the emergency department.

Background

Chest pain stands as one of the most frequently encountered complaints in emergency departments worldwide. While its etiology can span a spectrum from benign to life-threatening, it is crucial to distinguish between these categories for effective patient management. Serious causes of chest pain encompass aortic dissection, pulmonary embolism, and pneumothorax, demanding immediate attention.

On the other hand, non-emergent cardiac factors contributing to chest pain encompass valvular, infectious, or inflammatory conditions. Interestingly, a Study by Chen L et al. aimed to investigate the causes of chest pain in Chinese children and found that causes of chest pain in 7,251 children who visited the hospital during a 15-year period; 53.0% of the cases were idiopathic, 29.1% were related to Musculoskeletal diseases, 9.1% were related to respiratory diseases, 8.0% were cardiac, 0.6% were related to gastrointestinal diseases, 0.16% were related to mental diseases, and 0.04% were related to other conditions [1]. Nevertheless, according to this study, idiopathic chest pain was the most common cause of chest pain [1]. Muscloskeletal chest pain, strains, psychiatric conditions (including panic attacks), and systemic inflammatory and rheumatologic disorders round out the spectrum of potential causes in children, requiring thorough evaluation [1]. According to Januzzi et al., the cost of chest pain totals over 5 billion USD, with over 7 million presentations in emergency departments annually. Cardiovascular causes may be in up to 20% of patients presenting with chest discomfort; only 5.5% of these patients have an acute life-threatening condition, whereas more than 50% of patients presenting with chest discomfort receive a diagnosis of noncardiac pain [2]. On one hand, proper evaluation of chest pain must be done to rule out any significant issues, such as a myocardial infarction. Pope et al. discussed the complications of missed interventions, as missed myocardial infarctions can lead to a doubled risk of mortality after discharge [3]. On the other hand, prolonged assessment of all patients who present to the emergency department with chest pain is burdensome to all facets of the healthcare system. According to McCullough et al., the valuation per quality-adjusted life year (QALY) is over USD100,000 and would still be considered highly cost-ineffective compared with many other strategies and treatments for cardiovascular patients [4]. The goal of care should be to have a criterion that allows for efficient evaluation without unnecessary expenditures and waste of resources.

Chest pain in children without a prior history of cardiac abnormalities or significant family histories is unlikely to be related to a cardiac cause. According to a research article published in the Journal of Pediatric Health Care, a study of 50 children presenting to cardiology with chest pain had the following breakdown: 38 children (76%) had musculoskeletal/costochondral chest pain, 6 children (12%) had exercise-induced asthma, 4 children (8%) had chest pain resulting from gastrointestinal causes, and 2 children (4%) had chest pain resulting from psychogenic causes [5]. In an article written by Dr. Selbst in the Pediatric Clinics of North America journal, the approach to a child with chest pain should be taken seriously because the symptom of chest pain can cause great anguish to the child, disturbing their daily life, and can also create strain on the caretakers due to worry about a more malicious or dangerous pathology [6].

While chest pain in the pediatric population is even more rarely associated with a true cardiac etiology, some important information must be taken into consideration when reviewing past medical records or taking a history [7, 8]. The first would be a history of congenital heart disease. These conditions are often evaluated at birth and are noted for further management or observation in benign cases. Post-congenital causes of pediatric cardiac issues can include infections that can lead to cardiac inflammation, along with more systemic syndromes such as Rheumatic Fever and Kawasaki disease [6–8]. Genetic abnormalities and gene mutations can also lead to specific cardiac issues, such as dilated or hypertrophic cardiomyopathy and even a more systemic condition such as Marfan syndrome [6–8]. These conditions can all lead to chest pain being due to a cardiac etiology and can be effectively deduced through chart review, good history taking, and thorough physical examinations [7, 8]. The main objective of our study is to systematically review the literature that assesses the presentation, risk factors, and outcomes of pediatric patients who were admitted for cardiac chest pain.

Methods

This review was conducted per PRISMA guidelines [9]. All steps were done per the Cochrane Handbook of Systematic Reviews and Meta-analysis of Interventions [10]. Our research question was developed following the key elements of the PICO framework: Participants, Interventions, Comparison, and Outcomes [11]. The protocol was registered in PROSPERO), under number CRD42023397158

Inclusion and exclusion criteria

Both qualitative and quantitative studies were sought. Primary articles that focused on assessing the presentation, risk factors, and outcomes of pediatric (less than 21 years) patients who present to the ED with cardiac chest pain. In particular, articles that mentioned the incidence of cardiac-related chest pain were included in order to compare statistically to the general population of pediatric non-cardiac chest pain in the ED. Time limits were set from 2000 to the present and were included. Secondary or tertiary articles were excluded. Articles published before 2000 and non-English literature were excluded. Studies on the CP adult population (>21 years old), animals, or case series were also excluded. The list of excluded studies is included in the supplementary information. We also excluded studies performed only in urgent care, primary care, emergent medical services, or the ICU. There were no other restrictions regarding the type of ED, and studies performed in urban and community hospitals, public and private ED, academic and non-academic ED, trauma-center level I, II, and III will be included. Any patients aged 21 years or above who present to the ED with complaints of chest pain were excluded.

Data sources and study selection

The literature search strategies were developed using medical subject headings (MeSH) and text words related to chest pain in pediatrics. The following databases were queried for identifying peer-reviewed literature: MEDLINE, EMBASE, SCOPUS, and Web of Science. To ensure literature saturation, we scanned the reference lists of included studies and relevant reviews identified through the screening. Finally, we provided a bibliography of the included articles to the systematic review team. The most recent search was conducted in July 2023. The keywords used for the search are included in the attached supplement (S1 Appendix).

Screening was completed in two stages using the systematic review management program. Articles were screened for relevance based on the title and abstract and then evaluated for inclusion based on the full text. Two reviewers (M.S.Z and A.A.E) independently screened the titles and abstracts. The selection was focused only on peer-reviewed published studies. The reviewers read the full-text articles obtained and selected those that met all inclusion criteria. A third author (M.A) assisted in resolving any disagreements through consensus agreement. We used the input of two researchers at all stages of the analysis. A graphic of the screening and selection process can be seen in Fig 1.

Fig 1. Study selection process.

Fig 1

PRISMA flow diagram illustrating the process of study selection for the systematic review and meta-analysis.

Quality assessment of studies

Two assessors independently rated the quality of the studies using the Cochrane Collaboration’s tool. In addition, if discrepancies were presented, these were resolved through discussion and consensus between the analysts. The certainty of evidence was assessed using GRADE methodology [12].

Data extraction

Data were collected on the study characteristics: design, setting, population, sample size, and main objective. Data on prognostic factors and outcomes were also extracted: demographics, clinical presentation, associated symptoms, and risk factors. Missing information on prognostic factors or outcome was requested from the authors.

Data analysis

We extracted and analyzed the data regarding the prevalence of cardiac and non-cardiac emergency causes, which were pooled to calculate overall prevalence estimates with a 95% confidence interval (CI). The random effect model using the DerSimonian-Laird method was applied. We investigated the statistical heterogeneity between studies using the I2 statistics and chi-squared test, with p < 0.1 considered heterogeneous and I2 ≥ 50% suggestive of high heterogeneity. We conducted statistical analyses using Comprehensive Meta-Analysis Software (CMA).

Results

Results of the literature search

A total of 6520 records were identified through searching the four included databases, resulting in 19819 records after discarding the duplicates. Seventy-one records resulted from the title and abstract screening, and after the full-text screening, 11 records were finally included in our systematic review; of them, 10 studies were included in the meta-analysis [13–23]. The selection process is described in the PRISMA flow chart in Fig 1.

Characteristics of the included studies

Our search retrieved 11 studies with 3,052,540 children suffering from chest pain. The reported mean age for studied patients ranged from 10.1 in Massin et al. to 13 years in Pissarra et al. and Lin et al. [18, 19, 23]. All our included studies were retrospective cohorts in design except for Massin et al., which was prospective, and Mohan et al., whose study was quasi-experimental [19, 20]. Only three of our studies reported the location or radiation of pain; Pissarra et al. revealed that the commonest chest pain location among their patients was retrosternal, and Massin et al. reported that two locations were left-sided and diffuse chest pain [19, 23]. However, Ocampo-Vázquez et al. reported that 58% of their patients showed no pain radiation [22]. Throughout the studies, ECG, chest radiography, and Echocardiography were the most demanded investigations. Characteristics and a summary of our included research are displayed in Tables 1 and 2, respectively.

Table 1. Characteristics of the included studies.

Summary of studies on myocarditis and chest pain presentations, detailing study design, patient demographics, inclusion criteria, and observed symptoms. Beside the study ID the reference number of the study can be found.

Study ID Study Design Study arm, n Male, n (%) Age, M (sd) Site Inclusion criteria Medical history Family History disease Location or irradiation of the pain Associated symptoms
Babbitt 2022 [13] Retrospective cohort study 127 NR NR USA 1. Patients discharged from the PICU, with a discharge diagnosis of myocarditis or myopericarditis NR NR NR 1. Dyspnea, n = 23
2. The diagnosis of myocarditis was based on the clinical picture of acute deterioration of cardiac function requiring inotropic support, and endomyocardial biopsy was not required for the diagnosis of this study 2. Fever, n = 28
3. Myopericarditis was diagnosed based on chest pain during hospitalization, elevated troponin, and exclusion of other potential causes, such as coronary artery abnormalities. 3. Abdominal pain, n = 11
4. Vomiting, n = 15
5. URI symptoms, n = 24
Brancato 2021 [14] Retrospective cohort study 99 61 (62.9%) 12.5 Italy 1. Patients aged 0 to 19 years admitted for chest pain to the pediatric ED. Only 6 (23.1%) of 26 patients who presented a medical history and suggestive targets of cardiac pathology received a diagnosis of cardiac pathology Personal history of cardiac disease in 3 patients (3%) (2 with a small patent ductus arteriosus and 1 with previous closure of an atrial septal defect), tachycardia in 4 patients (4%), and palpitations in 4 patients (4%). NR 1. Syncope in 3 patients (3%)
2. Patients were included in the study if they had known minor congenital heart disease including left to right shunts and resolved lesions, or if they had no diagnosed lesion at the time of presentation. 2. Association with fever and asthenia in 4 patients (4%)
  3. Chest pain during physical activity in 8 patients (8.1%)
Drossner 2011 [15] Retrospective cohort study 4436 2237 (53%) 11 (3.66) USA 1. Age less than 19 years with a chief complaint of chest pain. Final review yielded 3% (148/4436) of patients excluded secondary to a documented history of congenital/ acquired cardiac disease. NR NR NR
Gesuete 2020 [16] Retrospective cohort study 737 430 (59%) 11 (1.16) Italy 1. Pediatric patients who presented with chest pain and were evaluated in a pediatric ED History of cardiac disease (n = 24) NR NR Cardiac-related Chest pain N = 8;
1. Fever 3 (37.5%)
2. Palpitations 0 (0%)
3. Exertional dyspnea 0 (0%)
4. Headache 0 (0%)
5. Gastrointestinal symptoms 0 (0%)
Non-cardiac chest Pain N = 729;
1.Fever 130 (17.8%)
2. Palpitations 31 (4.2%)
3. Exertional dyspnea 14 (1.9%)
4. Headache 15 (2%)
5. Gastrointestinal symptom 55 (7.5%)
Hambrook 2010 [17] Retrospective cohort study 3,043,873 1,361,611 (45%) 0–5 years 35019012, 6–11 years 74324124, 12–18 years 95044264 USA 1. Their age was less than 19 years during an ED visit for a chief complaint of CP. NR NR NR NR
Lin 2008 [18] Retrospective cohort study 103 64 (62.1%) 13 (2.17) Taiwan 1. Children under the age of 18 years who presented to the ED with the chief complaint of chest pain Seven (6.9%) patients reported a history of asthma. Two patients had mental retardation. Sudden death had been experienced in one family only. Two patients reported some psychogenic problems in their family members. NR 1. Fever or respiratory symptoms (cough, dyspnea) in 34
2. Gastrointestinal symptoms (epigastric pain, nausea, vomiting) in eight, dizziness in five, and palpitation in three.
Massin 2004 [19] Prospective cohort study GROUP A, n = 168 90 (53.57%) 10.1 (3.4) Belgium 1. Children younger than 16 years of age who presented to the emergency department with a primary complaint of chest pain One child in the cardiac category had a history of beta-thalassemia major and secondary hemochromatosis.14 One patient in the digestive category and 5 in the CW category had asthma; 1 case was diagnosed a few months after the presentation to the hospital. The family history was usually uneventful: the father of a child in the CW category had undergone an aortic valvuloplasty and the father of a child in the psychogenic group underwent a cordectomy. 1. Left-sided = 60 1. Anxiety 3
2. Right-sided = 18 2. Fever 13
3. Diffuse = 48 3. Cough 16
4. Sternal = 32 4. Dyspnea 6
5. Palpitations 19
6. Headache 1
7. Depression 1
8. Stressful event 12
9. Hyperventilation 1
10. Pain reproduced by palpation 23
11. Previous trauma 8
12. Pallor 4
13. Pathologic heart auscultation 18
14. Exercise-related pain 6
15. Meal-related pain 3
16. Vomiting 1
17. Hematemesis 1
GROUP B, n = 69 43(62.31%) 10.6 (2.9) The personal history was uneventful for the children in the CW category, except for one who had asthma and another one with a history of supraventricular tachycardia during infancy. One child in the cardiac group had a history of supraventricular tachycardia at birth without demonstrated recurrence beyond the neonatal period The family history of all the patients was uneventful. 1. Left-sided = 10 1. Palpitations 22
2. Right-sided = 0 2. Arrhythmia 2
3. Diffuse = 55
4. Sternal = 4
Mohan 2018 [20] A quasi-experimental design Pre-Pathway, n = 670 294 (43.6%) 12.4 (1.07) USA 1. Children aged 3 to 18 years old presenting with chest pain to the ED Patients were flagged for exclusion if they had a known alternative etiology for chest pain, such as sickle cell disease, gastroesophageal reflux (GER), or asthma, before the ED encounter. Patients who also had a known cardiac diagnosis or diagnosis that is known to have a high likelihood of presenting with chest pain (i.e. Marfan’s Syndrome) were also excluded NR NR NR
Post-Pathway, n = 1012 428 (42.3%) 12.1 (2.65)
Neff 2012 [21] Retrospective cohort study 400 201 (50.1%) 10.7 USA 1. Patients 18 years or younger presenting to a pediatric ED with a chief complaint of chest pain There were a significant number of patients with preexisting comorbid conditions, the most common of which were asthma and NR NR NR
congenital cardiac anomalies.
Ocampo-Vázquez 2019 [22] Retrospective cohort study 48 24 (50%) 10.9 (2.2) Mexico 1. Patients oscillated between 0 and 17 years without a clear predominance regarding the sex of the patients. All patients with previous cardiac pathologies and patients with chronic musculoskeletal problems under treatment were excluded from the study A total of four cases with a positive family history were found, these four cases had a family history of hypercholesterolemia, and in one case, a non-specified arrhythmia was found, in one other case, apart from the family background of hypercholesterolemia, the father also presented a family history of mitral insufficiency 1. Without irradiation n = 28 (58.3%) 1. None n = 19 (39.5%)
2. All of them went to the pediatric ER service to get a consult regarding precordial pain. 2. Retrosternal n = 8 (16.6%) 2. Dyspnea n = 17 (35.4%)
  3. Left arm n = 1 (2%) 3. Dysphagia n = 6 (12.5%)
  4. Left hypochondrium n = 3 (6.2%) 4. Syncope n = 5 (10.4%)
  5. Left hemithorax n = 2 (4.1%) 5. Anxiety n = 1 (2%)
  6. Neck n = 1 (2%) 6. Headache n = 1 (2%)
  7. Superior limbs n = 1 (2%) 7. Diaphoresis n = 1 (2%)
  8. Right arm n = 1 (2%) 8. Palpitations n = 1 (2%)
  9. Right hypochondrium n = 1 (2%) 9. Paresthesia n = 1 (2%)
  10. Right hemithorax n = 2 (4.1%) 10. Heartburn n = 1 (2%)
    11. Cough n = 1 (2%)
    12. Vomit n = 1 (2%)
Pissarra 2022 [23] Retrospective cohort study 798 370 (46.4%) 13 (2.67) Portugal 1. All admissions in pediatric ED with a chief complaint of chest pain 32.5% psychiatric (including a history of anxiety, depression, and attention deficit hyperactivity disorder), 28.3% respiratory (including a history of wheezing or asthma), and 18.9% cardiovascular (including a history of congenital heart defects or arrhythmia). NR 1. 33.7% mentioned it was a retrosternal pain 65.3% of the patients mentioned at least 1 additional symptom, in descent order of frequency: dyspnea, cough, palpitations, gastrointestinal symptoms (including abdominal pain, heartburn, nausea, and vomiting), dizziness or hypotonia, fever, asthenia or tiredness, and syncope.
2. 23.6% in the left hemithorax
3. 16.7% an anterior pain
4. 7.1% in the right hemithorax
5. 3.2% a posterior pain
6. 1.1% a subcostal pain.

Table 2. Clinical summary of the included studies.

Overview of studies examining cardiac and non-cardiac chest pain presentations, including methodologies, findings, and conclusions. Beside the study ID the reference number of the study can be found.

Study ID ED-work up (Resources) ECG findings Echocardiographic Findings ED-initial diagnosis Final/discharge diagnosis Cases of cardiac chest pain Cases of non-cardiac chest pain Others Conclusion
Babbitt 2022 [13] 1. ECG
2. Echocardiogram
3. Chest radiographs (CXRs)
58% had ST changes on initial ECG in cardiac chest pain patients NR NR 1. Cardiac chest pain, n = 58
2. Non- Cardiac chest pain, n = 69
1. Myopericarditis, n = 36
2. Myocarditis, n = 22
NR NR "Myopericarditis is a relatively common cause of chest pain for patients admitted to the pediatric intensive care unit, presents differently than true myocarditis, and carries a good prognosis"
Brancato 2021 [14] 1. ECG
2. Troponin
3. Echocardiographic
The ECG pattern was pathological in 23 (23.2%) of 99 patients. In particular, 14 patients showed ST changes or repolarization abnormalities, and 9 patients presented dysrhythmia. Of the 9 patients with dysrhythmia, 3 showed runs of paroxysmal supraventricular tachycardia (TPSV), 1 run of ventricular tachycardia, and 1 showed Wolff-Parkinson-White, and 4 showed premature ventricular contractions. No pathological Q waves were detected in any patient Echocardiographic examination was performed in all 9 cases with pathological ECG and/or TN of >0.03 ng/mL. 1. Yellow code, n = 66 (68%) 2. Green code, n = 32 (32%). Signs suggestive of cardiac pain (red flags) were detected in 26 patients (26.3%). Elements suggestive of respiratory pathology were found in 19 patients (19.2%). Medical history and physical examination suggestive of gastrointestinal pathology was found in 4 patients (4%). Two patients (2%) presented elements suggestive of psychogenic pathology. Twenty-eight patients (28.3%) did not refer to a specific etiology. 1. Idiopathic chest pain in 45 patients (45.4%)
2. Musculoskeletal in 20 patients (20.2%)
3. Respiratory pathology in 19 patients (19.3%)
4. Cardiovascular pathology in 6 patients (6.1%)
5. Psychogenic pathology in 5 patients (5%)
6. Gastrointestinal pathology in 4 patients (4.0%)
NR NR A total of 8 patients were then excluded: 2 for a history of cardiac surgery within the last year, 5 for previous Kawasaki disease, and 1 because affected by aortic stenosis and waiting for surgery. "Even with the low cost and the relative easiness for the plasma level determination, TN should be measured only in children with chest pain associated with a familiar history suggestive of cardiovascular disease and/or clinical symptoms and/or ECG alterations"
Drossner 2011 [15] Cardiac-related chest pain n = 24;
1. Chest radiograph 12 (50%)
2. Electrocardiogram 22 (92%)
3. Echocardiogram 14 (58%)
4. Laboratories 19 (79%)
Noncardiac chest pain n = 4264;
1. Chest radiograph 2282 (53%),
2. Electrocardiogram 1171 (27%)
3. Echocardiogram 51 (1%)
4. Laboratories 1118 (26%)
NR NR Seventy-three patients were initially identified as having cardiac-related chest pain. 1. Noncardiac chest pain was 56% of musculoskeletal disorders such as precordial pain, Tietze syndrome, and chest pain not otherwise specified (NOS).
2. Twelve percent were related to wheezing, asthma, and cough.
3. Eight percent of patients had infectious causes such as upper respiratory illness, pneumonia, fever, and pharyngitis.
4. Six percent of patients had gastrointestinal-related problems such as esophagitis, gastritis, or abdominal pain.
5. Finally, 4% of patients with noncardiac chest pain were related to sickle cell anemia.
6. The major breakdowns of cardiac diseases by category were dysrhythmia, 37% (9/24); pericardial disease, 29% (7/24); myocarditis, 17% (4/24); acute myocardial infarction, 13% (3/24); and pulmonary embolism, 4% (1/24).
1. Pericarditis, n = 6
2. Myocarditis, n = 4
3. Myocardial infarction, n = 3
4. Supraventricular tachycardia, n = 7
5. Long QT, n = 1
6. Ventricular tachycardia, n = 1
7. Pulmonary embolism, n = 1
8. Pneumopericardium, n = 1
NR NR “Cardiac-related chest pain in pediatric patients is rare but potentially serious. Arrhythmia was the most common cardiac-related etiology among this cohort. Those with myocarditis and myocardial infarction were the most acutely ill. An electrocardiogram in addition to history and physical examination was most useful in detecting relatively uncommon but significant cardiac-related chest pain. Using a thorough physical examination and potentially an electrocardiogram evaluation by a pediatric emergency care physician has an excellent rate of detection of cardiac-related causes”
Gesuete 2020 [16] Cardiac-related Chest pain N = 8;
1. Chest radiograph 4 (50%)
2. Electrocardiogram 8 (100%)
3. Echocardiogram 8 (100%)
4. Blood tests 6 (75%)
Noncardiac-related Chest pain N = 729;
1. Chest radiograph 117 (16%)
2. Electrocardiogram 145 (20%)
3. Echocardiogram 59 (8%)
4. Blood tests 56 (7%)
NR NR NR 1. Cardiac-related chest pain n = 8
2. Non- Cardiac chest pain n = 729; Musculoskeletal disorders n = 510
Respiratory disorders n = 88
Psychological disorders n = 73
gastrointestinal disorders n = 58
1. Pericardial disease n = 7 (87%)
2. Dysrhythmia n = 1 (13%)
NR Patients with a previously documented history of cardiac disease were excluded. Prior cardiac disease was defined as a known history of congenital/acquired heart disease, dysrhythmia, or cardiac surgery. “Chest pain is mainly due to benign causes and is a recurrent symptom in a high percentage of patients, associated with re-admission and school absenteeism”
Hambrook 2010 [17] 1. CBC (23%)
2. CXR (54%)
3. EKG (35%)
NR NR NR 1. Hematologic (0.3%)
2. Psychiatric (2.2%)
3. Cardiovascular (2.8%)
4. Gastrointestinal (6.4%)
5. Other (8.2%)
6. Respiratory (9.4%)
7. Trauma/Muskuloskeltal (12.8%)
8. Infectious (21.1%)
9. Chest Pain NOS (36.8%)
NR NR NR “Disparities exist in the ED care of pediatric patients with CP. Identification of such variations is important and provides an opportunity for targeted interventions that ensure delivery of high-quality, cost-effective health care for children”
Lin 2008 [18] 1. Chest radiography 101
2. Electrocardiography 87
3. Echocardiography 15
4. Panendoscopy 6
5. Complete blood count 64
6. Creatine kinase MB 51
Eighty-seven (84.5%) patients had ECG study, and four (4.6%) of them showed abnormalities, including first-degree atrioventricular (AV) block, Morbitz type 1 second-degree AV block, premature ventricular contraction, and Wolff-Parkinson-White syndrome. Echocardiograms were performed in 15 (14.6%) patients. No major anomaly was found; only six showed mitral valve prolapse. NR 1. Idiopathic 61 (59.2%)
2. Respiratory 25 (24.3%)
3. Musculoskeletal 7 (6.7%)
4. Gastrointestinal 6 (5.8%)
5. Cardiac 2 (2.0%)
6. Miscellaneous 2 (2.0%)
1. Arrhythmia 2 • Respiratory causes
1. Bronchitis 11
2. Pneumonia 5
3. Asthma 1
4. Pneumothorax 3
5. Hyperventilation 5
NR “The most common cause of chest pain prompting a child to visit the ED is idiopathic chest pain. The careful physical examination can reveal important clues and save many unnecessary examinations”
• Gastrointestinal causes
1. Gastritis 3
2. Gastroesophageal reflux 3
Massin 2004 [19] 1. ECG
2. Echocardiogram
3. Chest radiography
4. 24-hour Holter recording.
ECG (positive) = 83 Positive echocardiography 0 NR • Group A
1. Chest-wall pain (CW) was the most common diagnosis (64%).
2. Other causes included pulmonary (13%)
3. Psychological (9%)
4. Cardiac (5%)
5. Traumatic (5%)
6. Gastrointestinal problems (3%)
7. And 1 case of herpes zoster.
1. Cardiac problems were identified in only 9 patients: 3 patients had supraventricular reentry tachycardia, 2 had mitral valve prolapse, and 4 had sick sinus syndrome, myocarditis with extrasystole, Still disease with pericarditis, and cardiac hemochromatosis with left heart failure respectively. NR NR "The most important tools in assessing a child with acute chest pain in an emergency department are thorough history and physical examination. Assessment of recurrent chest pain is more difficult; arrhythmia and allergic and exercise-induced asthma may be underestimated when investigations are not performed"
The ECG was relevant to the diagnosis in the 2 cases with arrhythmia on auscultation: one child had intermittent atrial ectopic tachycardia and a second had severe supraventricular extrasystole. Positive echocardiography 0 • Group B
1. CW pain was also the most common diagnosis (89%).
2. Supraventricular tachyarrhythmia and exercise-induced asthma were demonstrated in 5 (7%) and 3 (4%) patients
NR
Mohan 2018 [20] 1. Echocardiogram
2. ECG
3. CXR
4. Troponin and CK
NR NR NR 1. A small minority of patients (11 patients) over the entire period was found to have a cardiac etiology for their chest pain
2. Unspecified Chest Pain (328)
3. Other Chest Pain (295)
4. Tietze’s Disease (190)
5. Unspecified Viral Infection (40)
6. Esophageal reflux (46)
7. Asthma Unspecified with acute exacerbation (26)
8. Acute Upper respiratory infection of unspecified site (33)
1. Four had myocarditis/myopericarditis
2. Two had pericarditis
3. Two had supraventricular tachycardia
4. Three presented with premature ventricular contractions (one was after blunt chest trauma from a motor vehicle accident).
5. Five of the eleven patients with cardiac disease presented post-pathway implementation and were all identified by the pathway.
NR NR "Overall, there was a low incidence of cardiac disease, and to our knowledge, no undiagnosed cardiac or life-threatening diagnoses. We believe this has led to general acceptance of the pathway in the ED and therefore there is an opportunity to further improve upon the pathway. As is the case for most pediatric conditions, efforts at improving quality of care will require ongoing measurement and modifications to our existing practice"
Neff 2012 [21] 1. 63.5% (n = 254) of the children underwent a CXR while in the ED as part of their evaluation. NR NR NR 1. Total Major Significance 19(7.4%)
2. Total Moderate Significance 2(0.8%)
3. Total Major/ Moderate 21(8.26%)
4. Total Minor Significance 11(4.3%)
5. Total Any Significance 32(12.56%)
6. Total No Significance 222(87.4%)
NR NR NR "This pilot study demonstrates the potential for a decision rule to eliminate both cost and radiation exposure by using defined criteria to determine the need for a CXR in pediatric ED patients. We identified 8 simple criteria that would have identified all children who benefited from a CXR in this study. The next phase of this study will prospectively evaluate the utility of each of the criteria as part of a draft decision rule"
Ocampo-Vázquez 2019 [22] 1. In 30 of the 48 patients, an electrocardiogram was performed
2. Of 48 patients, 32 had a thorax X-ray performed
In 30 of the 48 patients, an electrocardiogram was performed, of those 30 only 8 received abnormal results. All these studies were reviewed by a pediatric cardiologist who diagnosed five right branch blockings, one first-degree atrioventricular blocking with the left branch blocking, one sinus arrhythmia, and one sinus bradycardia. A total of three echocardiograms were performed in ER service, two were normal, and one presented pulmonary pressure of 40 mmHg. NR NR 1. Cardiac causes 1 (2%)
2. Musculoskeletal 20 (41.5%)
3. Respiratory 0 (0)
4. GastroIntestinal 14 (29%)
5. Psychological 13 (26.9%)
1. Pulmonary arterial hypertension 1 (2%) • Gastrointestinal causes
1. Gastroesophageal reflux disease n = 14 (29%)
NR “There was only one case associated with the presence of cardiac precordial pain pathology regarding pulmonary hypertension; this signified an incidence of 2% similar to what has been previously published in other articles”
• Psychological
1. Anxiety crisis 7 (14.5%)
2. Idiopathic 6 (12.4%)
Pissarra 2022 [23] 1. Electrocardiogram (ECG) was performed in 62.4%
2. Chest radiographs were ordered in 52.6%
3. Blood analysis was performed on 13%
4. Cardiac biomarkers were tested in 8.9%
All were evaluated by pediatric cardiology and performed ECG, with altered results in 77.7% NR NR 1. Musculoskeletal: 33%
2. Idiopathic: 24.4%
3. Psychogenic: 21.6%
4. Pulmonary chest pain occurred in 12.8%
5. Gastrointestinal 5.4%
6. Traumatic1.5%
7. Cardiac chest pain was reported in 1.1%
8. Miscellaneous 0.2%
1. Cardiac chest pain was reported in 1.1% of cases: 2 cases of arrhythmia, 2 of myocarditis, 3 of myopericarditis, and 2 of pericarditis. 1. Pulmonary chest pain occurred in 12.8% of the episodes, including acute asthma or wheezing, atypical and bacterial pneumonia, pneumothorax, and 1 case of plastic bronchitis. NR "Opposing to the low priority level in triage, benign diagnosis found, and low hospital admissions, there was a high percentage of complementary diagnostic tests performed with few altered results. In psychogenic chest pain, there was a low post-discharge referral. The authors highlight the importance of clinical algorithms to reduce unnecessary tests performed and readmissions and improve orientation and follow-up, particularly in psychogenic etiology"

Risk of bias assessment

Most of our included studies demonstrated good quality on NOS assessment. However, most of them did not have an adequate follow-up period. S1 Table shows the detailed assessment of each study and their score in the individual items of the three major domains of NOS (selection, comparability, and outcome).

Quality of studies

The quality of the studies can be viewed in S1 Table. The quality of each study was assessed according to the Newcastle Ottawa Scale. The scores obtained during the analysis ranged from 6 to 8, categorizing all our studies as intermediate to high quality. The overall average NOS score for our studies was 6.7. Given full consideration of our studies, we would categorize the overall quality as intermediate.

Cardiac versus non-cardiac chest pain causes and presentation

Although the cardiac causes of chest pain in our studied population were less common (2.5%), they should be considered in the evaluation of chest pain in order to be excluded. Thus, ECGs and echocardiograms were commonly obtained in patients presenting with chest pain. Pissarra et al. reported that obtained ECG results were abnormal in 77.7% of their patients with cardiac etiologies of chest pain, and Lin et al. reported that 84.5% of the patients had ECG abnormalities [18, 23]. Additionally, Brancato et al. reported that 23.2% of their patients’ ECGs were abnormal [14]. Cardiac causes of chest pain included myocarditis, pericarditis, myopericarditis, myocardial infarction, pulmonary embolism, pneumopericardium, and rhythm disturbances (supraventricular tachycardia, long QT syndrome, premature ventricular contraction). Reporting of previous causes varied among studies: Drossner et al. revealed that six patients had pericarditis, four had myocarditis, three had myocardial infarction, and seven had supraventricular tachycardia [15]; Gesuete et al. showed that 87% of cardiac causes were due to pericardial diseases and 13% were due to dysrhythmia [16]; Massin et al. reported that cardiac problems were identified in only 9 out of 130 patients: three patients had supraventricular reentry tachycardia, two had mitral valve prolapse, and four had sick sinus syndrome, myocarditis with extrasystole, Still disease with pericarditis and cardiac hemochromatosis with left heart failure, respectively [19].

On the other hand, non-cardiac chest pain causes were more commonly identified than cardiac causes (97.5% vs 2.5%). The non-cardiac causes reported in our included studies were as follows: respiratory, gastrointestinal, psychogenic, musculoskeletal, and idiopathic. Of these causes, Lin et al. reported that respiratory problems in their patients were bronchitis in 11 patients, pneumonia in five, asthma in one, pneumothorax in three, and hyperventilation in five, while gastrointestinal causes were due to gastritis in three patients and gastroesophageal reflux in three patients also [18]. Ocampo-Vázquez et al. reported that 29% of patients suffered from gastroesophageal reflux disease, while 14.5% of patients had anxiety crises and 12.4% of patients had idiopathic psychological causes for non-cardiac chest pain [22].

Meta-analysis findings

The prevalence of chest pain causes among the studied population visiting the emergency department was ranked as follows, from most to least common: non-cardiac, musculoskeletal, idiopathic, respiratory, psychogenic, gastrointestinal, and cardiac. Presented are a few specific findings of our analysis for each of these outcomes:

Cardiac causes

Ten studies reported cardiac causes of chest pain among our studied population [15–20, 22, 23]. The pooled prevalence was (0.025, 95% CI [0.013, 0.038]). The pooled studies were heterogeneous with I2 and p-value = (98.7% and > 0.001, respectively). The forest plot for cardiac chest pain outcome is illustrated in Fig 2.

Fig 2. Prevalence of cardiac chest pain.

Fig 2

Forest plot illustrating the prevalence of cardiac chest pain across different studies, showing point estimates with 95% confidence intervals and associated statistical parameters. Test for overall effect; p-value = 0.00004, Z-value = 4.0946. Heterogeneity; p-value> 0.001, I2 = 98.7%.

Non-cardiac causes

Non-Cardiac chest pain was reported in 10 studies with pooled prevalence = (0.975, 95% CI [0.962, 0.987]) [13–20, 22, 23]. I2 and p values were (98.7%, and > 0.001, respectively) showing that pooled studies were heterogeneous. The forest plot for non-cardiac chest pain outcome is shown in Fig 3.

Fig 3. Prevalence of non-cardiac chest pain.

Fig 3

Forest plot illustrating the prevalence of non-cardiac chest pain across different studies, showing point estimates with 95% confidence intervals and associated statistical parameters. Test for overall effect; p-value> 0.001, Z-value = 156.7. Heterogeneity; p-value> 0.001, I2 = 98.7%.

Respiratory causes

The overall prevalence of respiratory chest pain outcome pooled from eight studies was (0.13, 95% CI [0.092, 0.168]) [14–20, 22, 23]. The pooled studies were heterogeneous (I2 = 98.6%, p > 0.001). The forest plot for this outcome is illustrated in Fig 4.

Fig 4. Prevalence of respiratory chest pain.

Fig 4

Forest plot illustrating the prevalence of respiratory chest pain across different studies, showing point estimates with 95% confidence intervals and associated statistical parameters. Test for overall effect; p-value = 2.698, Z-value = 6.66. Heterogeneity; p-value> 0.001, I2 = 98.6%.

Gastrointestinal causes

Nine studies reported gastrointestinal chest pain outcome in the studied population [14–20, 22, 23]. The pooled prevalence was (0.053, 95% CI [0.039, 0.067]). The pooled studies were heterogeneous with I2 and p-value = (98.4% and > 0.001, respectively). The forest plot for gastrointestinal chest pain outcome is illustrated in Fig 5.

Fig 5. Prevalence of gastrointestinal chest pain.

Fig 5

Forest plot illustrating the prevalence of gastrointestinal chest pain across different studies, showing point estimates with 95% confidence intervals and associated statistical parameters. Test for overall effect; p-value = 1.243, Z-value = 7.412. Heterogeneity; p-value> 0.001, I2 = 98.4%.

Musculoskeletal causes

Musculoskeletal chest pain was reported in nine studies with pooled prevalence = (0.357, 95% CI [0.202, 0.512]) [14–20, 22, 23]. I2 and p values were (99.8%, and p > 0.001, respectively) showing that pooled studies were heterogeneous. The forest plot for this outcome is shown in Fig 6.

Fig 6. Prevalence of musculoskeletal chest pain.

Fig 6

Forest plot illustrating the prevalence of musculoskeletal chest pain across different studies, showing point estimates with 95% confidence intervals and associated statistical parameters. Test for overall effect; p-value = 6.198, Z-value = 4.52. Heterogeneity; p-value> 0.001, I2 = 99.8%.

Psychogenic causes

The overall prevalence of psychogenic chest pain outcome pooled from six studies was (0.11, 95% CI [0.043, 0.177]) [14, 16, 17, 19, 22, 23]. The pooled studies were heterogeneous (I2 = 98%, p > 0.001). The forest plot for psychogenic chest pain outcome is illustrated in Fig 7.

Fig 7. Prevalence of psychogenic chest pain.

Fig 7

Forest plot illustrating the prevalence of psychogenic chest pain across different studies, showing point estimates with 95% confidence intervals and associated statistical parameters. Test for overall effect; p-value = 0.0012, Z-value = 3.22. Heterogeneity; p-value> 0.001, I2 = 98%.

Idiopathic causes

Five studies reported idiopathic chest pain outcome among our studied population [14, 17, 18, 22, 23]. The pooled prevalence was (0.352, 95% CI [0.258, 0.446]). The pooled studies were heterogeneous with I2 and p-value = (96.6% and > 0.001, respectively). The forest plot for idiopathic chest pain outcome is illustrated in Fig 8.

Fig 8. Prevalence of idiopathic chest pain.

Fig 8

Forest plot illustrating the prevalence of idiopathic chest pain across different studies, showing point estimates with 95% confidence intervals and associated statistical parameters. Test for overall effect; p-value = 1.97, Z-value = 7.35. Heterogeneity; p-value> 0.001, I2 = 96.6%.

GRADE assessment

The certainty of evidence assessed in our systematic review is detailed in (S2 Table). According to GRADE, all outcomes were at a very low level of certainty. The causes of their downgrading were the heterogeneity of pooled studies in each assessed outcome and the publication bias as the observational studies are more attributable to it.

Discussion

This systematic review showed important information regarding the etiology of chest pain in children. This is perhaps the first metanalysis that explores the causes of pediatric chest pain. The estimated incidence of sudden cardiac death in children ranges from 0.6 to 6.2 deaths per 100,000, with hypertrophic cardiomyopathy, coronary artery anomalies, and malignant arrhythmias being responsible for many cases, while coinciding with athletic activities [24]. The risk and fear of misdiagnosing can create stressful scenarios for healthcare providers. This can lead to excessive diagnostic testing, which can create poor patient experiences as well as place a great financial burden on the healthcare system. Additionally, determining which children are at risk for sudden cardiac death is challenging due to the frequent lack of alarming symptoms.

Chest pain is common in children and accounts for 0.6% of pediatric emergency department visits [25]. Chest pain always raises concern of cardiac abnormalities, but it is rarely cardiac in origin. When it is, the consequences of misdiagnosis are quite serious. Accurate diagnosis is required to prevent unnecessary emergency department evaluation and cardiology referral. In most cases, after obtaining a thorough history and focused physical examination, no immediate intervention is needed. However, some children may have serious and life-threatening conditions, and a careful evaluation is required in every child presenting with chest pain to determine whether a cardiac condition may exist and guide the evaluation strategy [26]. In general, chest pain associated with exercise, syncope, or palpitations requires further evaluation and workup.

This study showed that cardiac causes of chest pain are rare in children. More specifically, our study shows that only 2.5% of our study population had chest pain that was secondary to a cardiac cause. This supports the previous findings that cardiac-related causes for chest pain in children are very rare [7, 25, 27]. It is worth noting that our review found variation in the specific cardiac pathologies among the included studies. This could have been due to several different factors such as patient location, demographics, institution of care, etc. Pericardial disease was found to be a cause in all three of the studies that mentioned pathological cardiac etiologies, however it was not the most prevalent in all three studies[27, 28].

Regarding specific pediatric cardiac causes, arrhythmias are implicated in many cardiac-related presentations [29]. Supraventricular tachycardia is the most common rhythm disturbance, and ventricular tachycardia or bradycardias are the most ominous rhythms [29]. These presentations are serious and require urgent evaluation and pediatric cardiology consultation.

Our review found 97.5% of our study population have a non-cardiac induced presentation of chest pain. The alternative causes of chest pain reported were respiratory, gastrointestinal, psychogenic, musculoskeletal, and idiopathic. The most prevalent non-cardiac cause of chest pain was musculoskeletal followed by idiopathic and then gastrointestinal. This is consistent with previous studies which have found these causes to be among the most common non-cardiac causes of pediatric chest pain [7, 8, 27]. Despite that there was still variation in the prevalence of these non-cardiac causes in the included studies. The cause of chest pain in many children remains unknown and warrants further investigation for a clearer understanding of pediatric chest pain etiology.

Our review also analyzed reports of chest pain location and radiation of pain to determine common presentations of children with cardiac pathologies. Among the studies that reported this information, the most common presentation of chest pain was retrosternal chest pain. Diffuse chest pain was the second most common reported type of pain. To our knowledge this is the first review to report chest pain location and radiation amongst a study population.

Our findings have clinical relevance and implications as algorithm-based policies are expanding nationally to limit reimbursement for visits for non-emergent causes. These algorithms derive emergent need for ED visits from billing codes rather than the presenting symptoms. It is therefore important to limit the diagnostic workup and reserve it for patients with positive findings on initial assessment. A set of red-flag criteria have been determined to help in the assessment of patients with chest pain [30]. Some red-flag criteria include, but are not limited to, exertional chest pain, exertional syncope, chest pain radiation, and past medical history of sudden cardiac death and hypercoagulable state. If a patient does not exhibit any red-flag criteria at all, then it is likely that the etiology of their chest pain is non-cardiac.

Limitations

This systematic review has several limitations. First, there was significant heterogeneity among the included studies. Second, many studies were retrospective, which did not allow the authors to determine the precise cause of chest pain due to the clinicians not being present at the time of presentation. These studies also have a small patient population with limited follow-up. Furthermore, these results should be interpreted cautiously because only eleven studies could be included in this review. This may be related to our reliance on a relatively limited number of databases for the identification of potentially eligible research studies. Also, it is susceptible to selection bias. There is always a potential for misclassification. For example, a patient may have a significant diagnosis but may be coded with that specific diagnosis rather than the more general chest pain.

Future considerations

In our systematic review, it was noted that the prevalence of cardiac pathologies differed among the included studies. The studies that reported on this all differed in location, demographics, and institution of care. A similar observation was made for the prevalence of non-cardiac causes of chest pain as well. These observations warrant more research to further understand the causes of such variations among study populations.

None of the studies that we reviewed categorized the chest pain location by the specific cause of chest pain. Further investigation is needed in this area of study as it could prove to be an essential tool in the practice of ED physicians who encounter pediatric patients with a chief complaint of chest pain. We also noticed heterogeneity of studies.

Conclusions

Chest pain in children, an infrequent occurrence, typically presents as benign in the realm of pediatric emergency departments and cardiologist’s offices. Within this context, the approach to evaluation is marked by its simplicity and efficacy. A comprehensive history-taking, meticulous physical examination, and a judicious screening electrocardiogram (ECG) often prove to be the sole requisites for excluding the exceedingly rare, yet potentially life-threatening, causes of chest pain in the pediatric population.

The use of laboratory tests remains a selective strategy, triggered only when warranted by the clinical presentation and the findings of the physical assessment. This approach prioritizes precision and resource optimization in the diagnostic process.

Through this study, we aim to enrich available resources at the disposal of physicians, empowering them to navigate the intricacies of assessing pediatric patients with chest pain presentations. By embracing this innovative approach, we hope to enhance the quality of care delivered while concurrently curbing the utilization of unnecessary investigations, thereby advancing pediatric medicine.

Practice points

Most children present with chest pain do not have an underlying cardiac cause. Although evaluation of chest pain is extensive, it rarely yields cardiac etiology. Extensive workup may not be needed in patients for whom a clear etiology, other than cardiac disease, can be determined.

Declarations

We confirm that the manuscript has been read and approved by all named authors and that there are no other persons who satisfy the criteria for authorship but are not listed.

We further confirm that the order of authors listed in the manuscript has been approved by all of us.

We confirm that we have given due consideration to the protection of intellectual property associated with this work and that there are no impediments to publication, including the timing of publication, with respect to intellectual property. In doing so, we confirm that we have followed the regulations of our institutions concerning intellectual property.

Supporting information

S1 Checklist. PRISMA checklist.

(DOCX)

pone.0294461.s001.docx (30.9KB, docx)
S1 Appendix. Literature search.

(DOCX)

pone.0294461.s002.docx (17.9KB, docx)
S1 Table. Assessing the quality of studies and evaluating the risk of bias using the Newcastle-Ottawa Quality Assessment Scale.

(PDF)

pone.0294461.s003.pdf (71.1KB, pdf)
S2 Table. Assessment of certainty for the etiologies of chest pain.

This table shows the certainty for the etiologies of chest pain.

(PDF)

pone.0294461.s004.pdf (28.3KB, pdf)

Abbreviations

CP

Chest Pain

NOS

Newcastle Ottawa Scale

ED

Emergency Department

ICU

Intensive Care Unit

Data Availability

All relevant data are within the paper and its Supporting Information files.

Funding Statement

The authors received no specific funding for this work.

References

  • 1.Chen L, Duan H, Li X, Yang Z, Jiao M, Sun K, et al. (2021). The Causes of Chest Pain in Children and the Criteria for Targeted Myocardial Enzyme Testing in Identifying the Causes of Chest Pain in Children. Front. Cardiovasc. Med. 8:582129. doi: 10.3389/fcvm.2021.582129 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Januzzi J. L. Jr, & McCarthy C. P. (2018). Evaluating chest pain in the emergency department: Searching for the optimal gatekeeper. Journal of the American College of Cardiology, 71(6), 617–619. [DOI] [PubMed] [Google Scholar]
  • 3.Pope J. H., Aufderheide T. P., Ruthazer R., Woolard R. H., Feldman J. A., Beshansky J. R., Griffith J. L., & Selker H. P. (2000). Missed diagnoses of acute cardiac ischemia in the emergency department. The New England Journal of Medicine, 342(16), 1163–1170 doi: 10.1056/NEJM200004203421603 [DOI] [PubMed] [Google Scholar]
  • 4.McCullough P. A., Ayad O., O’Neill W. W., & Goldstein J. A. (1998). Costs and outcomes of patients admitted with chest pain and essentially normal electrocardiograms. Clinical Cardiology, 21(1), 22–26 doi: 10.1002/clc.4960210105 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Saleeb SF, Li WY, Warren SZ, Lock JE. Effectiveness of screening for life-threatening chest pain in children. Pediatrics. 2011. Nov;128(5):e1062–8. doi: 10.1542/peds.2011-0408 [DOI] [PubMed] [Google Scholar]
  • 6.Selbst S. M. (2010). Approach to the child with chest pain. Pediatric clinics of North America, 57(6), 1221–1234. doi: 10.1016/j.pcl.2010.09.003 [DOI] [PubMed] [Google Scholar]
  • 7.Eslick GD. Epidemiology and risk factors of pediatric chest pain: a systematic review. Pediatr Clin North Am. 2010. Dec;57(6):1211–9. doi: 10.1016/j.pcl.2010.09.013 [DOI] [PubMed] [Google Scholar]
  • 8.Evangilista HA, Parsons M, Renneburg AK. Chest pain in children: diagnosis through history and physical examination. J Pediatr Health Care 2000;14:3. doi: 10.1016/s0891-5245(00)70037-x [DOI] [PubMed] [Google Scholar]
  • 9.Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. doi: 10.1136/bmj.n71 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al. Cochrane handbook for systematic reviews of interventions version 6.2 [updated February 2021]. Cochrane Handbook for Systematic Reviews of Interventions. 2021. [Google Scholar]
  • 11.Miller SA, Forrest JL. Enhancing your practice through evidence-based decision making: PICO, learning how to ask good questions. Journal of Evidence Based Dental Practice. 2001/10/01/ 2001;1(2):136–141. 10.1016/S1532-3382(01)70024-3. [DOI] [Google Scholar]
  • 12.Kirmayr M, Quilodrán C, Valente B, Loezar C, Garegnani L, Franco JVA. The GRADE approach, Part 1: how to assess the certainty of the evidence. Medwave. 2021. Mar 17;21(2):e8109. Spanish, English. doi: 10.5867/medwave.2021.02.8109 . [DOI] [PubMed] [Google Scholar]
  • 13.Babbitt MJ, Byrne F, Morphew T. Pediatric Myopericarditis Presenting to the Emergency Department as Chest Pain: A Comparative Study With Myocarditis. Pediatr Emerg Care. 2022. Feb 1;38(2):e761–e765. doi: 10.1097/PEC.0000000000002376 . [DOI] [PubMed] [Google Scholar]
  • 14.Brancato F, De Rosa G, Gambacorta A, Nunziata A, Ferrara P, Buonsenso D, et al. Role of Troponin Determination to Diagnose Chest Pain in the Pediatric Emergency Department. Pediatr Emerg Care. 2021. Dec 1;37(12):e1589–e1592. Italian, English. doi: 10.1097/PEC.0000000000002123 . [DOI] [PubMed] [Google Scholar]
  • 15.Drossner DM, Hirsh DA, Sturm JJ, Mahle WT, Goo DJ, Massey R, et al. Cardiac disease in pediatric patients presenting to a pediatric ED with chest pain. Am J Emerg Med. 2011. Jul;29(6):632–8. doi: 10.1016/j.ajem.2010.01.011 Epub 2010 Jul 13. . [DOI] [PubMed] [Google Scholar]
  • 16.Gesuete V, Fregolent D, Contorno S, Tamaro G, Barbi E, Cozzi G. Follow-up study of patients admitted to the pediatric emergency department for chest pain. Eur J Pediatr. 2020. Feb;179(2):303–308. doi: 10.1007/s00431-019-03495-5 Epub 2019 Nov 15. . [DOI] [PubMed] [Google Scholar]
  • 17.Hambrook JT, Kimball TR, Khoury P, Cnota J. Disparities exist in the emergency department evaluation of pediatric chest pain. Congenit Heart Dis. 2010. May-Jun;5(3):285–91. doi: 10.1111/j.1747-0803.2010.00414.x . [DOI] [PubMed] [Google Scholar]
  • 18.Lin CH, Lin WC, Ho YJ, Chang JS. Children with chest pain visiting the emergency department. Pediatr Neonatol. 2008. Apr;49(2):26–9. doi: 10.1016/S1875-9572(08)60007-8 . [DOI] [PubMed] [Google Scholar]
  • 19.Massin M.M., Bourguignont A., Coremans C., Comté L., Lepage P., Gérard P. Chest pain in pediatric patients presenting to an emergency department or to a cardiac clinic. Clin Pediatr 2004; 43: 231–238. [DOI] [PubMed] [Google Scholar]
  • 20.Mohan S, Nandi D, Stephens P, MʼFarrej M, Vogel RL, Bonafide CP. Implementation of a Clinical Pathway for Chest Pain in a Pediatric Emergency Department. Pediatr Emerg Care. 2018. Nov;34(11):778–782. doi: 10.1097/PEC.0000000000000861 ; PMCID: PMC5359077. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Neff J, Anderson M, Stephenson T, Young J, Hennes H, Suter R. REDUCE-PCP study: radiographs in the emergency department utilization criteria evaluation-pediatric chest pain. Pediatr Emerg Care. 2012. May;28(5):451–4. doi: 10.1097/PEC.0b013e31825355b5 . [DOI] [PubMed] [Google Scholar]
  • 22.Ocampo-Vázquez CM, Hernández-Benítez R, Iglesias-Leboreiro J, Bernardez-Zapata I, Luna MM, Cervantes-Izaguirre AP. Pediatric precordial pain, Hospital Español de México’s experience. Arch Cardiol Mex. 2019;89(1):26–32. English. doi: 10.24875/ACME.M19000005 . [DOI] [PubMed] [Google Scholar]
  • 23.Pissarra R, Pereira M, Amorim R, Neto BP, Lourenço L, Santos LA. Chest pain in a pediatric emergency department: clinical assessment and management reality in a third-level Portuguese hospital. Porto Biomed J. 2022. Jun 17;7(3):e150. doi: 10.1097/j.pbj.0000000000000150 ; PMCID: PMC9257298. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Andrew WB, Julian F: How to evaluate a child with chest pain. Curr Paediatr. 2004;14:64–70 [Google Scholar]
  • 25.Kocis KC. Chest pain in pediatrics. Pediatr Clin North Am. 1999. Apr;46(2):189–203. doi: 10.1016/s0031-3955(05)70112-7 [DOI] [PubMed] [Google Scholar]
  • 26.Sumski CA, Goot BH. Evaluating Chest Pain and Heart Murmurs in Pediatric and Adolescent Patients. Pediatr Clin North Am. 2020. Oct;67(5):783–799. doi: 10.1016/j.pcl.2020.05.003 [DOI] [PubMed] [Google Scholar]
  • 27.Leung AK, Robson WL, Cho H. Chest pain in children. Can Fam Physician. 1996. Jun;42:1156–60, 1163–4. [PMC free article] [PubMed] [Google Scholar]
  • 28.Pomerantz A, De Souza HG, Hall M, Neuman MI, Goyal MK, Samuels-Kalow ME, et al. Racial and Ethnic Differences in Insurer Classification of Nonemergent Pediatric Emergency Department Visits. JAMA Netw Open. 2023. May 1;6(5):e2311752. doi: 10.1001/jamanetworkopen.2023.11752 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Anderson BR, Vetter VL. Arrhythmogenic causes of chest pain in children. Pediatr Clin North Am. 2010. Dec;57(6):1305–29. doi: 10.1016/j.pcl.2010.09.005 [DOI] [PubMed] [Google Scholar]
  • 30.Harahsheh AS O’Byrne ML, Pastor B, Graham DA, Fulton DR. Pediatric Chest Pain-Low-Probability Referral: A Multi-Institutional Analysis From Standardized Clinical Assessment and Management Plans (SCAMPs®), the Pediatric Health Information Systems Database, and the National Ambulatory Medical Care Survey. Clin Pediatr (Phila). 2017. Nov;56(13):1201–1208. [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Antoine Fakhry AbdelMassih

25 Sep 2023

PONE-D-23-22358Presentation, Risk Factors, and Outcomes of Pediatric Patients who Present to the Emergency Department with Chest Pain: a systematic review and meta-analysisPLOS ONE

Dear Dr. Alsabri,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Nov 09 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Antoine Fakhry AbdelMassih

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please include a separate caption for each figure in your manuscript.

3. Please include your tables as part of your main manuscript and remove the individual files. Please note that supplementary tables (should remain/ be uploaded) as separate ""supporting information files"""

4. We notice that your supplementary tables are included in the manuscript file. Please remove them and upload them with the file type 'Supporting Information'. Please ensure that each Supporting Information file has a legend listed in the manuscript after the references list.

5. Please include a copy of Table 3 which you refer to in your text on page 8.

6. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information.

7. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: No

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: 1. The “Title” is inaccurate and incorrect. The “Title” modification is needed. Please, it is preferable to change it to “Chest Pain in Pediatric Patients in the Emergency Department-Presentation, Risk Factors and Outcomes-A Systematic Review and Meta-analysis”.

2. Regarding the initial phrase of the “Objective” of the “Abstract”; (This study sought to assess and determine…) is inappropriate. Please, change it to ‘This study aimed to assess and determine…).

3. The author (s) mentioned in the “Conclusion” of the “Abstract” this sentence (This review found musculoskeletal pain to the be most common cause of chest pain in children.) then the author (s) in mentioned this sentence (Review of our study population identified retrosternal chest pain to be the most common location of pain.). Please, both musculoskeletal pain and retrosternal chest pain are relevant to the entity of “location of pain” no more. So, both of the above sentences are contradictory and scientifically unacceptable. Please, review both and edit them.

4. The “Conclusion” of the “Abstract” is scientifically very weak. Re-writing it again is needed.

5. In the “Introduction”, for this sentence, “Statistically, many children with chest pain have gastrointestinal etiologies with referred chest pain”, please, support your sentence with numbers and percentages.

6. In the “Introduction”, also for this sentence, “Statistically, many children with chest pain have gastrointestinal etiologies with referred chest pain” is proceeded and followed with general writing sentences on “chest pain”. This is not a good understanding flow. The author (s) should mention some sentences regarding general “chest pain or chest pain in adults” and then start to specify writing on the “chest pain in pediatrics” or use a comparative method between “chest pain in children and adults”.

7. Naming of investigators; even in abbreviations and their work in this manuscript (M.A., Z.N., J.P., M.S.Z created the review protocol and a search strategy) in the “Methods” is a form of misplacement. So, please, transfer this sentence “Investigators (M.A., Z.N., J.P., M.S.Z) created the review protocol and a search strategy.” From “Methods” to the “Author contribution statement” section and change accordingly. Also, transfer this sentence “Two assessors (Z.N. and J.P.) independently rated the quality of the studies using the Cochrane Collaboration’s tool”. From “Quality assessment of studies” to the “Author contribution statement” section and change accordingly.

8. Please, where is the reference for (Figure 1) in the text?!

9. The following sentence in the “Limitations”; (Second, many studies were observational and retrospective, which did not allow the authors to determine the precise cause of chest pain) is incorrect and needs literature reviewing.

10. Regarding the final “Conclusion” it must be decisive, innovative, and expressive for the article. The “Conclusion” of the “Abstract” is also a brief reflective mirror of it.

11. Otherwise the included 2 studies (Drossner 2011; reference No. 6) and Massin 2004; reference No. 9). Where are the final references and their citation in the tables for the remaining included studies?!

12. There are several “Grammatical” mistakes. So, corrections and language editing are essential.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Attachment

Submitted filename: Review Comments.pdf

pone.0294461.s005.pdf (225.4KB, pdf)
PLoS One. 2024 Apr 16;19(4):e0294461. doi: 10.1371/journal.pone.0294461.r002

Author response to Decision Letter 0


11 Oct 2023

Response to Journal Requirements:

1. Thank you very much for your kindness in referencing the PLOS ONE style templates. We have reviewed them and adjusted the styling and format of the manuscript accordingly! Please let us know if there are still segments that are still not meeting the journal standards of formatting and style. Thank you!

2. Each figure was reviewed and ensured that a separate caption was given to each one.

3. We have pasted the tables as part of the main manuscript and removed the individual files. The supplementary tables have remained their own separate files.

4. The supplementary files were made into separate files and their legend was included at the end of the manuscript as per suggestion. Thank you!

5. This issue was resolved by removing the statement that referenced Table 3 as this was a mistake. We apologize for the confusion!

6. The caption and legends for the supplemental information was added to the end of the manuscript. Additionally we have updated some of the references accordingly with the journal style of formatting. Thank you for your guidance in this issue!

7. No additions or removals were made to the citation list.

Thank you so very much for the kind suggestions for the manuscript.

Response to reviewers

1. The title was changed as per the suggestion of the reviewer. Thank you!

2. This sentence was changed as per suggestions of the reviewer. Thank you!

3. We are having a little bit of difficulty understanding this point that was brought up. We understand musculoskeletal pain to be an etiology of pain as opposed to a means of localizing the pain. Retrosternal pain indicates a location in which any type of pain may be present. We are open to discussion and would love to further understand this issue to clarify it as much as possible for readers. Thank you for your help!

4. The conclusion of the abstract was re-written to be stronger. Thank you for pointing this out!

5. A reference was added to support this point. Thank you!

6. This portion of the introduction was changed as per suggestions of the reviewer. Thank you for advising us in making this section more coherent and better in flow!

7. The mentioned sentences were removed from their original locations and added to the author contributions portion of the manuscript. Thank you for clarifying this for us and making this wonderful suggestion!

8. The reference for Figure 1 was added into the text. Thank you!

9. This sentence was edited and the word observational was removed as there was some misunderstanding in this part. We meant to say only retrospective as this would make more sense because any physicians conducting the study would not be present at the time of patient encounter to directly examine the patients.

10. The conclusion was re-written to fall more in line with the reviewers suggestions. Thank you very much!

11. We have added in the references that were referred to in tables 1 and 2 that were used to conduct this study. Our apologies for this very obvious blunder. Thank you for your help in correcting this.

12. The manuscript was edited to correct for any grammatical errors.

Attachment

Submitted filename: Response to Reviewers1.docx

pone.0294461.s006.docx (16.6KB, docx)

Decision Letter 1

Antoine Fakhry AbdelMassih

2 Nov 2023

Presentation, Risk Factors, and Outcomes of Pediatric Patients who Present to the Emergency Department with Chest Pain: a systematic review and meta-analysis

PONE-D-23-22358R1

Dear Dr. Alsabri,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Antoine Fakhry AbdelMassih

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

The final comments of reviewer 1, are mainly focused on reference formatting, which can be handled during proofing. 

Thank you for fulfilling most of the required edits.

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: For the Author.

Thank you to the authors for the positive response in the correction of many of the reviewer comments. But, there are still few comments.

1. Unfortunately, the “Title; lines 1-3” is still unchanged. I don’t know why?! The “Title and abstract” are the face of the article, interestingly, attractive for readers, Journals, Conferences selection for presentation, and also a mirror for the authors.

2. Regarding the following sentence in the “Background”, “Statistically, many children with chest pain have gastrointestinal etiologies with referred chest pain”.

Regrettably, the author changed it to “However, the landscape shifts when considering pediatric cases, where statistical evidence points to gastrointestinal origins often leading to referred chest pain; lines 58-60” with no response to the reviewer's request (please, support your sentence with numbers and percentages). I don’t know, why? And there is no more difference between the first and the modified sentence.

3. The author (s) added (reference No. 14; line 60) to the above sentence “However, the landscape shifts when considering pediatric cases, where statistical evidence points to gastrointestinal origins often leading to referred chest pain [14]” as the first reference in the text citation How?! This is unacceptable. Please, arrange the references in serial order (1, 2, 3, 4,5…etc.). Serial order of the reference citing in the text is essential.

4. Regarding the addition of the defective references that were referred to in (Tables 1 and 2), thank you. But why do you neglect to add each No. of reference in brackets [] opposite each study ID in the tables rows themselves. Please, add the No. of reference in brackets [] in the right place of the tables.

5. Regarding the “Quality assessment of studies”, the reference citing (Kirmayr et al., 2021; lines 150) is a missed in the final references. Please, add it to the final reference list and put it in the text as a number in brackets [] with start this sentence with Kirmayr et al.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Dr. Yasser Mohammed Hassanain Elsayed

**********

Attachment

Submitted filename: Review Comments R1.docx

pone.0294461.s007.docx (19.4KB, docx)

Acceptance letter

Antoine Fakhry AbdelMassih

26 Feb 2024

PONE-D-23-22358R1

PLOS ONE

Dear Dr. Alsabri,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Prof Antoine Fakhry AbdelMassih

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Checklist. PRISMA checklist.

    (DOCX)

    pone.0294461.s001.docx (30.9KB, docx)
    S1 Appendix. Literature search.

    (DOCX)

    pone.0294461.s002.docx (17.9KB, docx)
    S1 Table. Assessing the quality of studies and evaluating the risk of bias using the Newcastle-Ottawa Quality Assessment Scale.

    (PDF)

    pone.0294461.s003.pdf (71.1KB, pdf)
    S2 Table. Assessment of certainty for the etiologies of chest pain.

    This table shows the certainty for the etiologies of chest pain.

    (PDF)

    pone.0294461.s004.pdf (28.3KB, pdf)
    Attachment

    Submitted filename: Review Comments.pdf

    pone.0294461.s005.pdf (225.4KB, pdf)
    Attachment

    Submitted filename: Response to Reviewers1.docx

    pone.0294461.s006.docx (16.6KB, docx)
    Attachment

    Submitted filename: Review Comments R1.docx

    pone.0294461.s007.docx (19.4KB, docx)

    Data Availability Statement

    All relevant data are within the paper and its Supporting Information files.


    Articles from PLOS ONE are provided here courtesy of PLOS

    RESOURCES